DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 8.22% to $18.31 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.33% to 18,179.98 and Dow Jones Industrial Average falling 0.61% to 41,794.60.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed $43.59 short of its 52-week high ($61.90), which the company achieved on July 31st.
The stock outperformed some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 4.08% to $4.85, Fortress Biotech Inc. (FBIO) fell 8.95% to $1.73, and Viking Therapeutics Inc. $(VKTX)$ fell 13.36% to $63.14.
Trading volume (551,298) remained 198,202 below its 50-day average volume of 749,500.
Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 04, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments